Seed loss through the urinary tract after prostate brachytherapy: examining the role of cystoscopy and urine straining post implant.
This study describes one institution's experience with seed retrieval through the urinary tract and makes recommendations for cystoscopy and urine straining post prostate brachytherapy (PB). 1794 patients from two separate cohorts covering different time periods (early versus late) were analyzed. All patients were preplanned with a modified peripheral loading technique and implanted with preloaded needles (125I or 103Pd) under ultrasound guidance. A catheter was used to delineate the urethra during the volume study but was not used during the implant. All patients underwent post implant cystoscopy. All patients were instructed to strain their urine for seven days post implant and return any seeds to our center. In our experience, seed loss through the urinary tract is a common event after PB, occurring in 29.7% of patients and was more common in patients from the early cohort, those implanted with 125I seeds or those patients with prior transurethral resection of the prostate. Average seed loss per case, however, represents only 0.58% of total activity. We continue to recommend routine post implant cystoscopy for seed retrieval and periprocedural management. We no longer recommend that patients strain their urine at home after documenting a low rate of seed loss after discharge.
Chicago Prostate Cancer Center, Westmont, Illinois 60559, USA.
Michael
M
Stutz
James
J
Petrikas
Michael
M
Raslowsky
Plato
P
Lee
Michelle
M
Gurel
Brian
B
Moran
D001918:Brachytherapy / Q000379:methods*; D006801:Humans; D007457:Iodine Radioisotopes / Q000652:urine; D008297:Male; D011467:Prostate; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D014551:Urinary Tract; D014556:Urine
D007457:Iodine Radioisotopes; D011868:Radioisotopes